GRI BIO, INC.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Sep 8, 2026 8-K
10-Q Aug 14, 2026 10-Q
SCHEDULE 13G/A Aug 13, 2026
8-K Jun 18, 2026 8-K
8-K May 14, 2026 8-K
SCHEDULE 13G/A May 13, 2026
10-Q May 13, 2026 10-Q
SCHEDULE 13G/A Feb 13, 2026
SCHEDULE 13G/A Feb 10, 2026
8-K Feb 4, 2026 8-K
EFFECT Jan 30, 2026
CORRESP Jan 30, 2026
UPLOAD Jan 30, 2026
10-K Jan 30, 2026 10-K
8-K Jan 30, 2026 8-K
424B5 Jan 30, 2026 424B5
S-3 Jan 30, 2026 S-3
S-8 Jan 30, 2026 S-8
8-K Jan 28, 2026 8-K
8-K Jan 21, 2026 8-K
8-K Jan 16, 2026 8-K
8-K Jan 15, 2026 8-K
8-K Jan 9, 2026 8-K
424B5 Jan 9, 2026 424B5
8-K Jan 8, 2026 8-K
← Newer Page 1 of 16 · 399 filings Older →